Carbonyl iron reduces anemia and improves effectiveness of treatment in under six-year-old children

Revista Brasileira de Hematologia e Hemoterapia

Iria L. G. Farias²  Elisangela Colpo¹  Salimara R. Botton¹  Rosirene B. Silveira¹  Adriane Fleig¹  Carlos Andre A. Schimitz¹  José Edson P. Silva¹ 

[1] ,Universidade Federal de Santa Maria Hospital Universitário Serviço de Hematologia/Oncologia RS

关键词: Iron deficiency anemia;    iron carbonyl;    ferrous sulfate;    children;    Anemia ferropriva;    ferro carbonila;    sulfato ferroso;    crianças;   

DOI  :  10.1590/S1516-84842009005000041

来源: SciELO

【 摘 要 】

The treatment of iron deficiency anemia in children usually consists in the use of ferrous sulfate solution, but this treatment does not always have the desired effectiveness. The aim of this study was to evaluate the effectiveness of chewable carbonyl iron tablets as an alternative for the treatment of iron deficiency anemia in under six-year-old children. Seventy-three children from Brazilian Family Health Units in Santa Maria, Brazil, were included in this study. One group received chewable carbonyl iron (CI) tablets and a control group received a solution of ferrous sulfate (FS) for 90 days, both at a dose of 5 mg/Kg/day. Blood was drawn from study participants at 0, 30 and 90 days of treatment to evaluate the whole blood test, ferritin concentration, serum iron, and total iron binding capacity. We also evaluated the acceptance and adherence to treatment, and the occurrence of side effects during treatment. Hemoglobin increased 1.3 g/dL in the CI Group and 1.2 g/dL in the FS group during the first 30 days of treatment. After 90 days of treatment, the CI Group had significantly better results for hematocrit, MCV, MCH, iron binding capacity and ferritin concentration compared to the FS Group. The ferritin concentration was significantly higher in the CI Group at the end of the treatment (9.51 ng/mL to 26.16 ng/mL). Additionally, the treatment was better accepted with fewer adverse effects by this group. Chewable carbonyl iron tablets should be considered an important therapeutic option in the treatment of iron deficiency anemia of under six-year-old children.

【 授权许可】

CC BY-NC-ND   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License